NasdaqGS - Nasdaq Real Time Price USD
Quince Therapeutics, Inc. (QNCX)
1.0500
0.0000
(0.00%)
At close: April 22 at 4:00:00 PM EDT
1.0500
0.00
(0.00%)
After hours: April 22 at 4:05:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-31,904
-31,904
-18,292
-44,038
-62,932
Investing Cash Flow
21,908
21,908
-5,758
18,002
58,952
Financing Cash Flow
-4,775
-4,775
143
707
6,808
End Cash Position
6,212
6,212
20,752
44,579
69,724
Capital Expenditure
-257
-257
-160
-133
-180
Issuance of Capital Stock
608
--
--
608
--
Repayment of Debt
--
--
-6
-49
--
Free Cash Flow
-32,161
-32,161
-18,452
-44,171
-63,112
12/31/2021 - 5/9/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TOVX Theriva Biologics, Inc.
1.3992
+6.81%
RLF.SW Relief Therapeutics Holding SA
2.3850
-6.47%
BCAB BioAtla, Inc.
0.3460
+2.10%
HTD.MU Corcept Therapeutics Inc
54.76
-5.42%
BT3.BE Lineage Cell Therapeutics Inc
0.3360
-6.67%
MVR0.BE Medivir AB
0.1346
-1.90%
0M4.DU Mersana Therapeutics Inc
0.3224
+2.12%
DBV.F DBV Technologies S.A.
1.2520
0.00%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
300759.SZ Pharmaron Beijing Co., Ltd.
22.55
+1.49%